Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$31.18
N/A
Last update: Oct 12, 12:57 PM
vTv Therapeutics Inc (VTVT) Stock Price, Quote, News & History
VTVTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of vTv Therapeutics (NASDAQ:VTVT) through any online brokerage.
Other companies in vTv Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
vTv Therapeutics has a consensus price target of $50.50.
The stock price for vTv Therapeutics (NASDAQ: VTVT) is $31.18 last updated October 12, 2026 at 12:57 PM EDT.
There are no upcoming dividends for vTv Therapeutics.
vTv Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for vTv Therapeutics.
vTv Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
